loadpatents
name:-0.054888010025024
name:-0.032500982284546
name:-0.0037589073181152
Chang-Lin; Joan-En Patent Filings

Chang-Lin; Joan-En

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chang-Lin; Joan-En.The latest application filed is for "ophthalmic compositions and methods for treating eyes".

Company Profile
3.38.46
  • Chang-Lin; Joan-En - Tustin CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ophthalmic Compositions And Methods For Treating Eyes
App 20210401789 - Vehige; Joseph G. ;   et al.
2021-12-30
Biodegradable Intravitreal Tyrosine Kinase Implants
App 20210121397 - EDELMAN; Jeffrey L. ;   et al.
2021-04-29
Biodegradable intravitreal tyrosine kinase implants
Grant 10,881,608 - Edelman , et al. January 5, 2
2021-01-05
Ophthalmic Compositions And Methods For Treating Eyes
App 20190365692 - Vehige; Joseph G. ;   et al.
2019-12-05
Ophthalmic compositions and methods for treating eyes
Grant 10,213,405 - Vehige , et al. Feb
2019-02-26
Biodegradable Intravitreal Tyrosine Kinase Implants
App 20190038551 - Edelman; Jeffrey L. ;   et al.
2019-02-07
Biodegradable intravitreal tyrosine kinase implants
Grant 10,076,492 - Edelman , et al. September 18, 2
2018-09-18
Ophthalmic Compositions And Methods For Treating Eyes
App 20180021282 - Vehige; Joseph G. ;   et al.
2018-01-25
Ophthalmic compositions and methods for treating eyes
Grant 9,668,997 - Vehige , et al. June 6, 2
2017-06-06
Enhanced Bimatoprost Ophthalmic Solution
App 20160354384 - CHANG; CHIN-MING ;   et al.
2016-12-08
Ophthalmic Compositions And Methods For Treating Eyes
App 20160256424 - Vehige; Joseph G. ;   et al.
2016-09-08
Enhanced Bimatoprost Ophthalmic Solution
App 20160250225 - Chang; Chin-Ming ;   et al.
2016-09-01
Biodegradable Intravitreal Tyrosine Kinase Implants
App 20160199297 - Edelman; Jeffrey L. ;   et al.
2016-07-14
Ophthalmic compositions and methods for treating eyes
Grant 9,254,324 - Vehige , et al. February 9, 2
2016-02-09
Enhanced bimatoprost ophthalmic solution
Grant 9,241,918 - Chang , et al. January 26, 2
2016-01-26
Enhanced Bimatoprost Ophthalmic Solution
App 20160015717 - CHANG; CHIN-MING ;   et al.
2016-01-21
Biodegradable intravitreal tyrosine kinase implants
Grant 9,233,070 - Edelman , et al. January 12, 2
2016-01-12
Enhanced bimatoprost ophthalmic solution
Grant 9,155,716 - Chang , et al. October 13, 2
2015-10-13
Enhanced Bimatoprost Ophthalmic Solution
App 20150087713 - Chang; Chin-Ming ;   et al.
2015-03-26
Enhanced bimatoprost ophthalmic solution
Grant 8,933,120 - Chang , et al. January 13, 2
2015-01-13
Enhanced bimatoprost ophthalmic solution
Grant 8,933,127 - Chang , et al. January 13, 2
2015-01-13
Ophthalmic Compositions And Methods For Treating Eyes
App 20140256675 - Vehige; Joseph G. ;   et al.
2014-09-11
Enhanced bimatoprost ophthalmic solution
Grant 8,772,338 - Chang , et al. July 8, 2
2014-07-08
Ophthalmic compositions and methods for treating eyes
Grant 8,729,125 - Vehige , et al. May 20, 2
2014-05-20
Enhanced Bimatoprost Ophthalmic Solution
App 20140100287 - Chang; Chin-Ming ;   et al.
2014-04-10
Ophthalmic Compositions And Methods For Treating Eyes
App 20140045939 - Vehige; Joseph G. ;   et al.
2014-02-13
Ophthalmic Compositions And Methods For Treating Eyes
App 20140045773 - Vehige; Joseph G. ;   et al.
2014-02-13
Biodegradable Intravitreal Tyrosine Kinase Implants
App 20140031408 - Edelman; Jeffrey L. ;   et al.
2014-01-30
Compositions and methods for the intraocular transport of therapeutic agents
Grant 8,637,571 - Hughes , et al. January 28, 2
2014-01-28
Method For Determining Optimum Intraocular Locations For Drug Delivery Systems
App 20140010823 - Robinson; Michael R. ;   et al.
2014-01-09
Enhanced bimatoprost ophthalmic solution
Grant 8,586,630 - Chang , et al. November 19, 2
2013-11-19
Ophthalmic compositions and methods for treating eyes
Grant 8,569,370 - Vehige , et al. October 29, 2
2013-10-29
Ophthalmic compositions and methods for treating eyes
Grant 8,569,367 - Vehige , et al. October 29, 2
2013-10-29
Method for determining optimum intraocular locations for drug delivery systems
Grant 8,571,802 - Robinson , et al. October 29, 2
2013-10-29
Enhanced bimatoprost ophthalmic solution
Grant 8,524,777 - Chang , et al. September 3, 2
2013-09-03
Biodegradable intravitreal tyrosine kinase implants
Grant 8,512,738 - Edelman , et al. August 20, 2
2013-08-20
Enhanced Bimatoprost Ophthalmic Solution
App 20130203854 - Chang; Chin-Ming ;   et al.
2013-08-08
Enhanced Bimatoprost Ophthalmic Solution
App 20130197093 - CHANG; Chin-Ming ;   et al.
2013-08-01
Ophthalmic Compositions And Methods For Treating Eyes
App 20130190398 - Vehige; Joseph G. ;   et al.
2013-07-25
Enhanced Bimatoprost Ophthalmic Solution
App 20130102678 - Chang; Chin-Ming ;   et al.
2013-04-25
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
Grant 8,409,607 - Hughes , et al. April 2, 2
2013-04-02
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
Grant 8,404,267 - Hughes , et al. March 26, 2
2013-03-26
Enhanced bimatoprost ophthalmic solution
Grant 8,338,479 - Chang , et al. December 25, 2
2012-12-25
Enhanced Bimatoprost Ophthalmic Solution
App 20120316243 - Chang; Chin-Ming ;   et al.
2012-12-13
Enhanced Bimatoprost Ophthalmic Solution
App 20120289603 - Chang; Chin-Ming ;   et al.
2012-11-15
Enhanced bimatoprost ophthalmic solution
Grant 8,309,605 - Chang , et al. November 13, 2
2012-11-13
Enhanced bimatoprost ophthalmic solution
Grant 8,299,118 - Chang , et al. October 30, 2
2012-10-30
Enhanced bimatoprost ophthalmic solution
Grant 8,278,353 - Chang , et al. October 2, 2
2012-10-02
Enhanced Cimatoprost Ophthalmic Solution
App 20120142782 - Chang; Chin-Ming ;   et al.
2012-06-07
Enhanced Bimatoprost Ophthalmic Solution
App 20120142783 - Chang; Chin-Ming ;   et al.
2012-06-07
Enhanced Bimatoprost Ophthalmic Solution
App 20110124737 - Chang; Chin-Ming ;   et al.
2011-05-26
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
Grant 7,931,909 - Hughes , et al. April 26, 2
2011-04-26
Retinoid-containing Sustained Release Intraocular Implants And Related Matters
App 20110076318 - Hughes; Patrick M. ;   et al.
2011-03-31
Enhanced bimatoprost ophthalmic solution
Grant 7,851,504 - Chang , et al. December 14, 2
2010-12-14
Compositions And Methods For The Intraocular Transport Of Therapeutic Agents
App 20100222587 - HUGHES; Patrick M. ;   et al.
2010-09-02
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
Grant 7,771,742 - Hughes , et al. August 10, 2
2010-08-10
Compositions and methods for the intraocular transport of therapeutic agents
Grant 7,714,024 - Hughes , et al. May 11, 2
2010-05-11
OPHTHALMIC COMPOSITIONS COMPRISING dDC
App 20100056547 - Hughes; Patrick M. ;   et al.
2010-03-04
Retinoid-containing Sustained Release Intraocular Implants And Related Methods
App 20090163550 - HUGHES; Patrick M. ;   et al.
2009-06-25
Enhanced Bimatoprost Ophthalmic Solution
App 20090149546 - Chang; Chin-Ming ;   et al.
2009-06-11
Sustained Release Intraocular Inplants Containing Tyrosine Kinase Inhibitors And Related Methods
App 20080260803 - HUGHES; Patrick M. ;   et al.
2008-10-23
Sustained Release Intraocular Implants Containing Tyrosine Kinase Inhibitors And Related Methods
App 20080254096 - HUGHES; Patrick M. ;   et al.
2008-10-16
Method For Determining Optimum Intraocular Locations For Drug Delivery Implant
App 20080181929 - Robinson; Michael R. ;   et al.
2008-07-31
Ocular Therapy Using Alpha-2 Adrenergic Receptor Anterior Compounds Having Enhanced Clearance Rates
App 20080112922 - HUGHES; Patrick M. ;   et al.
2008-05-15
Ocular Therapy Using Alpha-2 Adrenergic Receptor Anterior Compounds Having Enhanced Clearance Rates
App 20080112923 - HUGHES; Patrick M. ;   et al.
2008-05-15
Compositions and methods for the intraocular transport of therapeutic agents
App 20070066541 - Hughes; Patrick M. ;   et al.
2007-03-22
Ocular therapy using alpha-2 adrenergic receptor anterior compounds having enhanced clearance rates
App 20060257452 - Hughes; Patrick M. ;   et al.
2006-11-16
Drug Delivery To The Back Of The Eye
App 20060258617 - Lyon; Robert T. ;   et al.
2006-11-16
Enhanced bimatoprost ophthalmic solution
App 20060211770 - Chang; Chin-Ming ;   et al.
2006-09-21
Methods for treating ocular conditions with cyclic lipid contraining microparticles
App 20060182781 - Hughes; Patrick ;   et al.
2006-08-17
Ophthalmic compositions and methods for treating eyes
App 20060106104 - Vehige; Joseph G. ;   et al.
2006-05-18
Retinoid-containing sustained release intraocular drug delivery system and related methods
App 20050271705 - Hughes, Patrick M. ;   et al.
2005-12-08
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
App 20050244470 - Hughes, Patrick M. ;   et al.
2005-11-03
Biodegradable intravitreal tyrosine kinase implants
App 20050244475 - Edelman, Jeffrey L. ;   et al.
2005-11-03
Drug delivery to the back of the eye
App 20050234018 - Lyons, Robert T. ;   et al.
2005-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed